Guided Bone Regeneration Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
302 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5918302

The global guided bone regeneration (GBR) market reported revenue of approximately US$ 780 million in 2024, and it is expected to reach a valuation of US$ 1150 million by the end of 2031. The market's growth is driven by the increasing prevalence of oral diseases, technological advancements, and the adoption of innovative products.

Key Market Insights

Guided bone regeneration is a technique in the field of dentistry used for hard tissue reconstruction. The market for GBR is witnessing significant growth due to the rising number of dental disorders, technological advancements, and the increasing number of dental practitioners.

Market Growth Drivers

1. Rising Oral Diseases: The prevalence of oral diseases is on the rise, leading to an increased use of bone substitutes for dental procedures. GBR techniques play a critical role in dental hard tissue reconstruction.
2. Technological Advancements: Ongoing technological improvements have led to the development of synthetic bone substitutes that are gradually replacing natural bone grafts. Hybrid grafts, combining osteogenic cells and growth factors, are a significant development in the field.
3. Increasing Number of Dental Practitioners: The growing number of dental practitioners is contributing to the demand for oral care and related products, including guided bone regeneration materials.

Growing Demand for Innovative Products

Researchers are continually working on material development to enhance the efficacy and mode of action of GBR materials. The emergence of the vegan sector has also prompted manufacturers to create plant-based substitutes for xenograft and allograft materials, known as phycografts, to cater to the growing vegan population and address religious considerations.

Barriers to Market Growth

One of the primary challenges in GBR procedures is clinical complications, particularly related to membrane resorption. Resorbable membranes may have uncontrolled resorption periods, and non-resorbable membranes require a second surgical procedure for removal, which can hinder the healing process. Addressing these complications is an area for development to reduce patient morbidity and expenses.

Booming U.S. Market

The United States is a leading market for guided bone regeneration due to its high elderly population, established market leaders, and increased investments in the industry. The country's market is expanding as dental implant procedures increase.

Lucrative German Market

Germany is expected to be a lucrative market for guided bone regeneration providers due to the increasing prevalence of dental diseases with higher severity levels, leading to more dental implant procedures.

Emerging Chinese Market

China's market for guided bone regeneration materials is growing alongside the increasing number of dental diseases among the aging population. The country's demand for GBR materials is expected to rise significantly in the coming years.

Competitive Landscape

Key market players are actively involved in new product launches, expanding into emerging markets, forming partnerships for technological advancements, conducting research and development activities, and acquiring small companies to drive business growth.

Key Companies Profiled:

Baxter International Inc.
Medtronic
Stryker Corp.
Integra LifeSciences
Zimmer Biomet Holdings
Dentsply Sirona
botiss biomaterials GmbH
Geistlich Pharma AG
Biotech Dental
Dentegris GmbH
GENOSS Co., Ltd.
Osstem Implant

The global guided bone regeneration market is poised for significant growth, driven by the increasing prevalence of oral diseases, technological advancements, and the adoption of innovative products.

Market Segmentation

By Material:

Bone Graft Substitutes
Allograft
Xenograft
Synthetic Bone Graft
Others
Barrier Membranes
Expanded Polytetrafluoroethylene (e-PTFE)
High-density Polytetrafluoroethylene (d-PTFE)
Titanium Mesh and Titanium-reinforced PTFE

By Application:

Implantology
Periodontology
Oral and Maxillofacial Surgery
Others

By End User:

Hospitals
Dental Clinics
Academic & Research Centers
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Guided Bone Regeneration Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Guided Bone Regeneration Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Guided Bone Regeneration Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Guided Bone Regeneration Market Outlook, 2018 - 2031

5.1. Global Guided Bone Regeneration Market Outlook, by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Bone Graft Substitutes
5.1.1.1.1. Allograft
5.1.1.1.2. Xenograft
5.1.1.1.3. Synthetic Bone Graft
5.1.1.1.4. Others
5.1.1.2. Barrier Membranes
5.1.1.2.1. Expanded Polytetrafluoroethylene (e-PTFE)
5.1.1.2.2. High-density Polytetrafluoroethylene (d-PTFE)
5.1.1.2.3. Titanium Mesh and Titanium-reinforced (PTFE)
5.2. Global Guided Bone Regeneration Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Implantology
5.2.1.2. Periodontology
5.2.1.3. Oral and Maxillofacial Surgery
5.2.1.4. Others
5.3. Global Guided Bone Regeneration Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Dental Clinics
5.3.1.3. Academic & Research Centers
5.3.1.4. Ambulatory Surgical Centers
5.4. Global Guided Bone Regeneration Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa

6. North America Guided Bone Regeneration Market Outlook, 2018 - 2031

6.1. North America Guided Bone Regeneration Market Outlook, by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Bone Graft Substitutes
6.1.1.1.1. Allograft
6.1.1.1.2. Xenograft
6.1.1.1.3. Synthetic Bone Graft
6.1.1.1.4. Others
6.1.1.2. Barrier Membranes
6.1.1.2.1. Expanded Polytetrafluoroethylene (e-PTFE)
6.1.1.2.2. High-density Polytetrafluoroethylene (d-PTFE)
6.1.1.2.3. Titanium Mesh and Titanium-reinforced (PTFE)
6.2. North America Guided Bone Regeneration Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Implantology
6.2.1.2. Periodontology
6.2.1.3. Oral and Maxillofacial Surgery
6.2.1.4. Others
6.3. North America Guided Bone Regeneration Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Dental Clinics
6.3.1.3. Academic & Research Centers
6.3.1.4. Ambulatory Surgical Centers
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Guided Bone Regeneration Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.2. U.S. Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.3. U.S. Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.4. Canada Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.5. Canada Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.6. Canada Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Guided Bone Regeneration Market Outlook, 2018 - 2031

7.1. Europe Guided Bone Regeneration Market Outlook, by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Bone Graft Substitutes
7.1.1.1.1. Allograft
7.1.1.1.2. Xenograft
7.1.1.1.3. Synthetic Bone Graft
7.1.1.1.4. Others
7.1.1.2. Barrier Membranes
7.1.1.2.1. Expanded Polytetrafluoroethylene (e-PTFE)
7.1.1.2.2. High-density Polytetrafluoroethylene (d-PTFE)
7.1.1.2.3. Titanium Mesh and Titanium-reinforced (PTFE)
7.2. Europe Guided Bone Regeneration Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Implantology
7.2.1.2. Periodontology
7.2.1.3. Oral and Maxillofacial Surgery
7.2.1.4. Others
7.3. Europe Guided Bone Regeneration Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Dental Clinics
7.3.1.3. Academic & Research Centers
7.3.1.4. Ambulatory Surgical Centers
7.3.2. Attractiveness Analysis
7.4. Europe Guided Bone Regeneration Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Germany Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.2. Germany Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.3. Germany Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.4. U.K. Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.5. U.K. Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.6. U.K. Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.7. France Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.8. France Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.9. France Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.10. Italy Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.11. Italy Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.12. Italy Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.13. Turkey Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.14. Turkey Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.15. Turkey Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.16. Russia Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.17. Russia Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.18. Russia Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.19. Rest of Europe Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.20. Rest of Europe Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.21. Rest of Europe Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Guided Bone Regeneration Market Outlook, 2018 - 2031

8.1. Asia Pacific Guided Bone Regeneration Market Outlook, by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Bone Graft Substitutes
8.1.1.1.1. Allograft
8.1.1.1.2. Xenograft
8.1.1.1.3. Synthetic Bone Graft
8.1.1.1.4. Others
8.1.1.2. Barrier Membranes
8.1.1.2.1. Expanded Polytetrafluoroethylene (e-PTFE)
8.1.1.2.2. High-density Polytetrafluoroethylene (d-PTFE)
8.1.1.2.3. Titanium Mesh and Titanium-reinforced (PTFE)
8.2. Asia Pacific Guided Bone Regeneration Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Implantology
8.2.1.2. Periodontology
8.2.1.3. Oral and Maxillofacial Surgery
8.2.1.4. Others
8.3. Asia Pacific Guided Bone Regeneration Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Dental Clinics
8.3.1.3. Academic & Research Centers
8.3.1.4. Ambulatory Surgical Centers
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Guided Bone Regeneration Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. China Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.2. China Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.3. China Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.4. Japan Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.5. Japan Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.6. Japan Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.7. South Korea Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.8. South Korea Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.9. South Korea Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.10. India Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.11. India Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.12. India Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.13. Southeast Asia Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.14. Southeast Asia Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.15. Southeast Asia Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.16. Rest of Asia Pacific Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.17. Rest of Asia Pacific Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.18. Rest of Asia Pacific Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Guided Bone Regeneration Market Outlook, 2018 - 2031

9.1. Latin America Guided Bone Regeneration Market Outlook, by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Bone Graft Substitutes
9.1.1.1.1. Allograft
9.1.1.1.2. Xenograft
9.1.1.1.3. Synthetic Bone Graft
9.1.1.1.4. Others
9.1.1.2. Barrier Membranes
9.1.1.2.1. Expanded Polytetrafluoroethylene (e-PTFE)
9.1.1.2.2. High-density Polytetrafluoroethylene (d-PTFE)
9.1.1.2.3. Titanium Mesh and Titanium-reinforced (PTFE)
9.2. Latin America Guided Bone Regeneration Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Implantology
9.2.1.2. Periodontology
9.2.1.3. Oral and Maxillofacial Surgery
9.2.1.4. Others
9.3. Latin America Guided Bone Regeneration Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Dental Clinics
9.3.1.3. Academic & Research Centers
9.3.1.4. Ambulatory Surgical Centers
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Guided Bone Regeneration Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.2. Brazil Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.3. Brazil Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.4. Mexico Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.5. Mexico Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.6. Mexico Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.7. Argentina Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.8. Argentina Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.9. Argentina Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.10. Rest of Latin America Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.11. Rest of Latin America Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.12. Rest of Latin America Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Guided Bone Regeneration Market Outlook, 2018 - 2031

10.1. Middle East & Africa Guided Bone Regeneration Market Outlook, by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Bone Graft Substitutes
10.1.1.1.1. Allograft
10.1.1.1.2. Xenograft
10.1.1.1.3. Synthetic Bone Graft
10.1.1.1.4. Others
10.1.1.2. Barrier Membranes
10.1.1.2.1. Expanded Polytetrafluoroethylene (e-PTFE)
10.1.1.2.2. High-density Polytetrafluoroethylene (d-PTFE)
10.1.1.2.3. Titanium Mesh and Titanium-reinforced (PTFE)
10.2. Middle East & Africa Guided Bone Regeneration Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Implantology
10.2.1.2. Periodontology
10.2.1.3. Oral and Maxillofacial Surgery
10.2.1.4. Others
10.3. Middle East & Africa Guided Bone Regeneration Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Hospitals
10.3.1.2. Dental Clinics
10.3.1.3. Academic & Research Centers
10.3.1.4. Ambulatory Surgical Centers
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Guided Bone Regeneration Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. GCC Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.2. GCC Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.3. GCC Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.4. South Africa Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.5. South Africa Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.6. South Africa Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.7. Egypt Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.8. Egypt Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.9. Egypt Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.10. Nigeria Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.11. Nigeria Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.12. Nigeria Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.13. Rest of Middle East & Africa Guided Bone Regeneration Market by Material, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.14. Rest of Middle East & Africa Guided Bone Regeneration Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.15. Rest of Middle East & Africa Guided Bone Regeneration Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By End User vs by Application Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Baxter International Inc.
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Medtronic
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Stryker Corp.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Integra LifeSciences
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Zimmer Biomet Holdings
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Dentsply Sirona
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. botiss biomaterials GmbH
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Geistlich Pharma AG
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Biotech Dental
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. Dentegris GmbH
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Baxter International Inc.
Medtronic
Stryker Corp.
Integra LifeSciences
Zimmer Biomet Holdings
Dentsply Sirona
botiss biomaterials GmbH
Geistlich Pharma AG
Biotech Dental
Dentegris GmbH
GENOSS Co.,Ltd.
Osstem Implant

Methodology

LOADING...